Protara Therapeutics (TARA) Common Equity (2013 - 2026)
Protara Therapeutics' Common Equity was $161.31 million in Q2 2026, up 11.7% from $144.42 million a year earlier but down 11.0% from the prior quarter.
Protara Therapeutics (TARA) Common Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Protara Therapeutics came in at $196.41 million, up 17.5% from FY2024.
- Common Equity shows a five-year compound annual growth rate of -0.3% (FY2020 to FY2025).
- In earlier years, Common Equity was $167.13 million in FY2024 (+144.6%), $68.32 million in FY2023 (-33.1%), $102.08 million in FY2022 (-37.0%) and $161.91 million in FY2021 (-18.7%).
- Quarterly Common Equity has moved between $58.41 million (Q1 2024) and $196.41 million (Q4 2025) over five years.
- Compared with a year earlier, Common Equity has increased for nine straight quarters, with growth averaging 60.6% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q1 2025 (growth of 171.3%); the worst was Q3 2023 (a decline of 44.7%).
- Per Business Quant data, TARA's Common Equity in the three quarters before Q2 2026 was $181.21 million (Q1 2026), $196.41 million (Q4 2025) and $132.29 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Protara Therapeutics | 192.02 Mn | 192.02 Mn | - | 161.31 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 161.31 Mn |
| Mar 31, 2026 | 181.21 Mn |
| Dec 31, 2025 | 196.41 Mn |
| Sep 30, 2025 | 132.29 Mn |
| Jun 30, 2025 | 144.42 Mn |
| Mar 31, 2025 | 158.48 Mn |
| Dec 31, 2024 | 167.13 Mn |
| Sep 30, 2024 | 81.79 Mn |
| Jun 30, 2024 | 92.05 Mn |
| Mar 31, 2024 | 58.41 Mn |
| Dec 31, 2023 | 68.32 Mn |
| Sep 30, 2023 | 76.96 Mn |
| Jun 30, 2023 | 85.23 Mn |
| Mar 31, 2023 | 94.77 Mn |
| Dec 31, 2022 | 102.08 Mn |
| Sep 30, 2022 | 139.18 Mn |
| Jun 30, 2022 | 145.46 Mn |
| Mar 31, 2022 | 152.24 Mn |
| Dec 31, 2021 | 161.91 Mn |
| Sep 30, 2021 | 170.41 Mn |
Protara Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=TARA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "TARA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=TARA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();